Examining Asian American subgroups separately is crucial to understanding distinctions among them and how these differences affect their risk of type 2 diabetes and CVD, a new AHA statement says.
An expert panel recommended restricting the expanded first-line indication to patients whose metastatic castration-resistant prostate tumors have BRCA mutations.